Retrospective Analysis of the Effects of Non-Compliance with Denosumab on Changes in Bone Mineral Density During the COVID-19 Pandemic

PURPOSE: Although denosumab is a safe and effective treatment for osteoporosis in various clinical trials, few studies have investigated its efficacy in specific clinical situations. The effect of non-compliance with the standard six-month dosing regimen for denosumab on bone mineral density (BMD) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chun-Feng, Shiao, Ming-Shi, Mao, Tso-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289459/
https://www.ncbi.nlm.nih.gov/pubmed/34290494
http://dx.doi.org/10.2147/PPA.S316144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289459/
https://www.ncbi.nlm.nih.gov/pubmed/34290494
http://dx.doi.org/10.2147/PPA.S316144

Ejemplares similares